SOD2 and exocrine pancreatic carcinoma: We have recently shown that the sod2 promoter is hypermethylated in multiple myeloma (Hodge et al, 2005a), so we sought to determine if hypermethylation may be an explanation for the decreased expression of SOD2 observed in pancreatic carcinoma cell lines.